The document provides an analysis of investments tied to Portugal’s Golden Visa funds, detailing 26 publicly disclosed companies linked to six specific funds. Here’s a summary of the key points:
Overview
- Transparency Focus: The analysis aims to showcase the transparency of investments rather than reflecting the whole market or the amounts invested.
- Investment Categories: Funds are categorized under venture capital, private equity, energy, debt, or technology.
Geographic Distribution
- Lisbon Dominance: 15 out of 23 Portuguese companies are headquartered in Lisbon, followed by Porto (5), Coimbra (2), and Aveiro (1).
Sector Analysis
- Financial Services Lead: 6 companies are in financial services, followed by energy and utilities (5), consumer and communications (4), biotech and foodtech (4), industry and infrastructure (3), and forestry and materials (1).
Private-Company Disclosures
- Some firms listed, like Valvian and Immunethep, have headquarters in various Portuguese districts, illustrating a wider geographic spread.
Investment Instruments
- The report emphasizes the difference between direct investments in companies versus purchasing existing shares/bonds in the secondary market, which does not directly benefit the companies.
Visibility Limitations
- Not all investments are publicly disclosed uniformly; some funds provide details while others do not, making it challenging to trace every euro invested.
Non-Portuguese Holdings
- Some investments are outside Portugal, as the legal framework allows funds to invest up to 40% outside the country, which affects the analysis of investment distribution.
Conclusion
- The analysis is based on public records and highlights potential gaps in investment value reporting, emphasizing a need for care in assessing the true nature of investments.
For more detailed insights, refer back to the specific reports and company disclosures linked in the document.
